B
BLAB
vs
S
S&P TSX Composite Index (Canada)
Over the past 12 months, BLAB has significantly outperformed S&P TSX Composite Index (Canada), delivering a return of +54% compared to the S&P TSX Composite Index (Canada)'s +33% growth.
Stocks Performance
BLAB vs S&P TSX Composite Index (Canada)
Performance Gap
BLAB vs S&P TSX Composite Index (Canada)
Performance By Year
BLAB vs S&P TSX Composite Index (Canada)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Britannia Life Sciences Inc
Glance View
Britannia Life Sciences, Inc. is a global product development platform. The company is headquartered in Toronto, Ontario. The company went IPO on 2017-12-01. The firm's platform offers an integrated suite of services to assist companies along their product development journey. The firm provides product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally. The company is also engaged in the development and regulatory approval of topical and edible cannabis products, including preparation and support for food authorizations. The company serves consumer packaged goods (CPG), cosmetics, household goods and nutraceutical industries, blue-chip, food and beverage, nutraceutical sectors, toiletries, small and medium enterprise (SME) clients.
